MDK-66671

Details

Stereochemistry	ACHIRAL
Molecular Formula	C23H23Cl2N3O3
Molecular Weight	460.353
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=NC(=CC(NCCC2=CC=C(Cl)C=C2Cl)=N1)C3=CC=CC(=C3)C(C)(C)C(O)=O

InChI

InChIKey=FJKKCRCBBAXLQZ-UHFFFAOYSA-N

InChI=1S/C23H23Cl2N3O3/c1-23(2,21(29)30)16-6-4-5-15(11-16)19-13-20(28-22(27-19)31-3)26-10-9-14-7-8-17(24)12-18(14)25/h4-8,11-13H,9-10H2,1-3H3,(H,29,30)(H,26,27,28)

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Prostanoid DP receptor 16 Target ID: CHEMBL4427 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21147533	Antagonist 2849		8.57 null [pIC50]

PubMed

Title	Date	PubMed
Understanding DP receptor antagonism using a CoMSIA approach.	2011-01-01	21147533

Name

Type

Language

MDK-66671

Code

English

MDK66671

Preferred Name

English

2-(3-(6-((2-(2,4-DICHLOROPHENYL)ETHYL)AMINO)-2-METHOXYPYRIMIDIN-4-YL)PHENYL)-2-METHYLPROPIONIC ACID

Systematic Name

English

BENZENEACETIC ACID, 3-(6-((2-(2,4-DICHLOROPHENYL)ETHYL)AMINO)-2-METHOXY-4-PYRIMIDINYL)-.ALPHA.,.ALPHA.-DIMETHYL-

Systematic Name

English

Code System Code Type Description

PUBCHEM

11669780

Created by admin on Mon Mar 31 19:50:52 GMT 2025 , Edited by admin on Mon Mar 31 19:50:52 GMT 2025

PRIMARY

CAS

885066-67-1

Created by admin on Mon Mar 31 19:50:52 GMT 2025 , Edited by admin on Mon Mar 31 19:50:52 GMT 2025

PRIMARY

FDA UNII

JXZ83H2X06

Created by admin on Mon Mar 31 19:50:52 GMT 2025 , Edited by admin on Mon Mar 31 19:50:52 GMT 2025

PRIMARY

ACTIVE MOIETY


					JXZ83H2X06

MDK-66671